Charcot-Marie-Tooth disease axonal type 2Q (CMT2Q) is a rare inherited nerve disease that mainly damages the long nerves in the arms and legs (peripheral nerves). It belongs to the Charcot-Marie-Tooth (CMT) group of disorders, which are hereditary motor and sensory neuropathies. In CMT2Q, the main problem is injury to the axon, the long “wire” part of the nerve that carries signals, rather than the myelin covering. MalaCards+1 CMT2Q is caused by a harmful change (mutation) in a gene called DHTKD1, which makes a mitochondrial protein involved in energy and amino-acid metabolism. When this gene does not work properly, the nerve cells do not get enough stable energy, and over time their axons slowly degenerate, especially in the longest nerves to the feet and hands. MalaCards+2Wikipedia+2
Charcot-Marie-Tooth disease axonal type 2Q (CMT2Q) is a very rare, inherited nerve disease that mainly affects the long nerves going to the feet and hands. It is an axonal neuropathy, which means the core of the nerve fiber (the axon) is damaged rather than the myelin coating. In most reported families it is autosomal dominant, so one changed copy of the gene is enough to cause the disease.MalaCards+1
Most people with CMT2Q start to notice problems in the teenage years or early adult life. The main problems are slowly worsening weakness and thinning of muscles in the lower legs and, later, in the hands. People often develop high-arched feet (pes cavus), foot drop, loss of ankle reflexes, and reduced feeling in the feet. The disease usually progresses slowly and symmetrically, meaning both sides of the body are affected in a similar way.MalaCards+1
CMT2Q is usually autosomal dominant. This means a person can develop the disease if they inherit one changed copy of the DHTKD1 gene from either parent. Men and women are affected equally, and each child of an affected parent has a 50% chance of inheriting the faulty gene. Symptoms usually begin from the teenage years to adulthood and slowly get worse over many years. NCBI+2MalaCards+2
Clinically, CMT2Q causes slowly progressive weakness and wasting of muscles in the feet and lower legs, reduced or absent reflexes at the ankles, high-arched feet (pes cavus), and mild to moderate loss of deep sensation (for example, joint position and vibration sense). The disease is very rare, with an estimated frequency of less than 1 in 1,000,000 people worldwide. ClinMed Journals+3MalaCards+3Orpha.net+3
Other names
Doctors and genetic databases may use several other names for Charcot-Marie-Tooth disease axonal type 2Q. All of the names below refer to the same basic condition:
Charcot-Marie-Tooth disease, axonal, type 2Q
Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2Q
Autosomal dominant Charcot-Marie-Tooth disease type 2Q
Charcot-Marie-Tooth neuropathy, type 2Q
Charcot-Marie-Tooth neuropathy, axonal, type 2Q
DHTKD1-related Charcot-Marie-Tooth disease type 2Q
These different names emphasize that it is a CMT type 2 (axonal) disease, that it is autosomal dominant, and that it is linked to disease-causing variants in the DHTKD1 gene. NCBI+2MalaCards+2
Types
CMT2Q is one small part of the larger CMT family. To understand it better, it helps to see where it sits in the overall classification:
CMT1 – demyelinating forms
In CMT1, the main damage is to the myelin sheath, the insulation around the nerve axon. Nerve conduction is slow, and genetic causes often involve myelin proteins such as PMP22. NCBI+1CMT2 – axonal forms
In CMT2, including CMT2Q, the main damage is to the axon itself. Nerve conduction velocities are often near normal, but the signal size (amplitude) is reduced because fewer axons are working. Many genes can cause CMT2, and each subtype (2A, 2B, 2Q, etc.) is linked to a different gene. NCBI+2Wikipedia+2CMT2Q – a specific axonal subtype
CMT2Q is one rare subtype within CMT2 and is specifically linked to mutations in DHTKD1 on chromosome 10p14. It usually shows adolescent to adult onset, distal weakness, reduced reflexes, pes cavus, and deep sensory loss. MalaCards+2PubMed+2Other CMT groups (CMT4, CMTX, etc.)
Other groups include autosomal-recessive demyelinating forms (CMT4) and X-linked forms (CMTX), which are genetically and clinically different from CMT2Q. They are mentioned only to show that CMT2Q is one very specific niche inside a complex classification. NCBI+1
Causes
Very important note:
Medically, the only proven primary cause of CMT2Q is a disease-causing mutation in the DHTKD1 gene. The list below breaks this into detailed mechanisms and contributing factors that help explain how and why the disease appears and how it may become more severe.
Pathogenic DHTKD1 gene mutation
The core cause of CMT2Q is a harmful (pathogenic) variant in DHTKD1, often a nonsense or loss-of-function mutation that stops the protein from working normally. This change has been shown in large families and animal models to directly cause axonal neuropathy. Ma’ayan Lab+3MalaCards+3Wikipedia+3Autosomal dominant inheritance pattern
Because the disease is autosomal dominant, inheriting just one mutated copy of DHTKD1 from an affected parent is enough to cause disease. This pattern explains why the condition runs strongly in some families across generations. NCBI+2MalaCards+2De novo (new) DHTKD1 mutation in the patient
In some rare cases of autosomal dominant diseases, the mutation may appear newly in the child (de novo) even when both parents are healthy. This can also be a cause of CMT2Q if a new mutation occurs in the DHTKD1 gene in early development. Wikipedia+1Loss of DHTKD1 enzyme activity in mitochondria
DHTKD1 is part of the 2-oxoadipate dehydrogenase complex in mitochondria and helps break down amino acids like lysine and tryptophan. Mutations reduce this enzyme’s activity, disturbing normal energy metabolism inside nerve cells. Cell+3Wikipedia+3Wikipedia+3Energy failure in long peripheral axons
Long peripheral nerves need a steady supply of ATP (cell energy). When DHTKD1 function is impaired, mitochondrial ATP production is reduced, and long axons become especially vulnerable to degeneration, leading to the distal pattern of weakness in CMT2Q. Wikipedia+2PMC+2Build-up of metabolic by-products
DHTKD1 mutations can cause accumulation of organic acids like 2-oxoadipate and 2-aminoadipate, which are normally broken down in the lysine pathway. These substances may be toxic at high levels and can stress nerve cells. PubMed+2Cell+2Increased mitochondrial oxidative stress
Faulty 2-oxoadipate dehydrogenase activity can increase production of reactive oxygen species (ROS) in mitochondria. Extra ROS can damage proteins, lipids, and DNA in nerve cells and contribute to slow axonal degeneration. Wikipedia+1Abnormal myelination secondary to axonal dysfunction
Even though CMT2Q is an axonal disease, mouse models show abnormal myelination and reduced large axon diameter. Disturbed axon-glia signalling may lead to thinner or unstable myelin, which further weakens nerve conduction. PMC+2SpringerLink+2Dysregulation of myelin protein zero (MPZ) expression
Experimental work suggests that altered DHTKD1 function can disturb the regulation of MPZ mRNA in Schwann cells. MPZ is a major myelin protein. Abnormal MPZ expression can harm myelin structure and indirectly cause axonal damage. Semantic Scholar+1Length-dependent nerve vulnerability
The longest nerves, especially to the feet, are naturally more vulnerable because signals and nutrients must travel farther. Any mild metabolic defect (like DHTKD1 dysfunction) tends to hit these long axons first, explaining why symptoms start in the feet. Wikipedia+1Genetic modifiers and background genes
Other genes related to mitochondrial function, myelin, or axonal transport may modify how severe CMT2Q becomes. While DHTKD1 is the main cause, the total genetic background can influence disease onset age and progression. Wikipedia+2Neurology Asia+2Founder mutations in specific families
Some large families share the same DHTKD1 mutation passed down from a distant ancestor (founder effect). In such families, almost all affected members have the same genetic cause and similar clinical features. MalaCards+2Ma’ayan Lab+2Age-related nerve degeneration
As people age, nerve repair and mitochondrial function naturally decline. In someone with a DHTKD1 mutation, this age-related change can push axons past a threshold, making symptoms appear or worsen in adulthood. Genetic Rare Diseases Center+2Wikipedia+2Metabolic stress (illness, severe under-nutrition)
Serious infections, poor nutrition, or major surgery can temporarily increase metabolic demand and oxidative stress. In a person with DHTKD1-related mitochondrial weakness, such stress may accelerate nerve damage and symptom progression. Wikipedia+1Co-existing exposure to neurotoxic drugs
Certain chemotherapy drugs, alcohol abuse, and some other medications can cause or worsen peripheral neuropathy. In someone with CMT2Q, these exposures do not cause the disease but can add extra damage to already fragile axons. Wikipedia+2LearnHaem | Haematology Made Simple+2Co-existing diabetes or glucose intolerance
Diabetes is a well-known cause of peripheral neuropathy. If a person with CMT2Q also has long-standing, poorly controlled diabetes, diabetic nerve injury can add on top of the inherited axonal damage and make symptoms more severe. LearnHaem | Haematology Made Simple+2Physiopedia+2Vitamin deficiencies (e.g., vitamin B12)
Low levels of vitamins important for nerve health, especially vitamin B12, folate, or B6, can cause additional neuropathy. In someone with CMT2Q, correcting these deficiencies will not cure the genetic disease but may prevent extra avoidable nerve damage. LearnHaem | Haematology Made Simple+1Repeated mechanical stress on weak feet
High arches, foot drop, and unstable ankles can lead to repeated ankle sprains, calluses, and pressure points. Over time, this mechanical stress can worsen pain, deformities, and functional disability, even though it is not the root genetic cause. ClinMed Journals+2ResearchGate+2Physical inactivity and muscle deconditioning
Because walking becomes harder, people may reduce activity. Long-term inactivity leads to more muscle wasting and joint stiffness, so weakness seems worse than the nerve damage alone would cause. Regular safe exercise and physiotherapy can limit this effect. Physiopedia+1Co-existing metabolic DHTKD1-related disorders
Some individuals with DHTKD1 variants also show features of 2-aminoadipic and 2-oxoadipic aciduria, a metabolic disease of lysine breakdown. Although the exact relationship is still being studied, this dual involvement suggests more global metabolic stress that may further harm nerves. Wikipedia+3PubMed+3Cell+3
Symptoms of Charcot-Marie-Tooth disease axonal type 2Q
Slowly progressive weakness in feet and ankles
The earliest and most common symptom is weakness in the muscles that lift and move the feet and ankles, making it harder to walk, run, or stand on toes. The weakness develops slowly over years rather than suddenly. Wikipedia+3MalaCards+3PubMed+3Muscle wasting in lower legs (“stork legs”)
Because the nerves supplying the lower leg muscles do not work well, the muscles shrink over time. The legs may appear thin below the knees with relatively normal thighs, giving a “stork leg” or “inverted champagne bottle” look. MalaCards+2NCBI+2Foot drop and high-stepping gait
Weakness of the muscles that lift the front of the foot causes foot drop, so the toes drag during walking. To avoid tripping, people often raise their knees higher than usual, creating a high-stepping gait. Wikipedia+2NCBI+2High-arched feet (pes cavus)
Many people with CMT2Q develop pes cavus, where the arch of the foot is very high and rigid. This is caused by an imbalance between weak and relatively strong muscles in the foot. It can make shoe fitting and balance more difficult. ResearchGate+3MalaCards+3NCBI+3Claw toes or hammertoes
The imbalance between muscles that flex and extend the toes can lead to clawing or hammering of the toes. This can cause pain, calluses, and problems with wearing normal shoes. Wikipedia+2ClinMed Journals+2Reduced or absent ankle reflexes
When a doctor taps the Achilles tendon with a hammer, the normal ankle jerk reflex may be weak or absent in CMT2Q. This finding reflects reduced nerve input to the muscle and is a classic sign of peripheral neuropathy. MalaCards+2NCBI+2Numbness and reduced sensation in feet and toes
Sensory fibers are also affected, so people often feel numbness, reduced ability to feel light touch, and reduced sense of vibration in the feet and toes. This loss of sensation is usually mild to moderate but can affect balance and safety. MalaCards+2Wikipedia+2Tingling, pins-and-needles, or burning feelings
Some patients describe paresthesias such as tingling, “pins and needles,” or burning in the feet. These feelings come from irritated or mis-firing sensory nerve fibers. Symptoms are often worse at night or after long standing. Wikipedia+1Loss of deep sensation (joint position and vibration)
Deep sensory fibers that tell the brain where joints are in space can be affected. People may have difficulty feeling the position of their toes or ankles with eyes closed, and vibration from a tuning fork may feel weak or absent. MalaCards+2NCBI+2Weakness in hands and fingers (later)
As the disease progresses, similar axonal damage can affect hand and forearm nerves, leading to weak grip, difficulty with buttons or small objects, and mild wasting of the small hand muscles. This usually appears after leg symptoms. Wikipedia+2Physiopedia+2Balance problems and unsteadiness
A combination of weak ankle muscles, foot deformities, and loss of deep sensation makes it harder to keep balance, especially in the dark or on uneven ground. People may sway, feel unsteady, or fall more often. Wikipedia+2Physiopedia+2Fatigue and tired legs with activity
Walking with weak muscles and foot deformities costs more energy. Patients often report tiredness or aching in the legs after relatively short distances. This fatigue is due both to muscle weakness and inefficient gait. Physiopedia+1Mild neuropathic pain
Some individuals experience burning, shooting, or aching pain in their feet and sometimes calves. Pain is often mild to moderate and may fluctuate. In many people with CMT, pain is less prominent than weakness, but it can affect quality of life. Wikipedia+1Skeletal deformities such as scoliosis (in some cases)
In some CMT patients, long-standing muscle imbalance around the spine can lead to scoliosis (sideways curvature). While not specific to CMT2Q, it can appear as part of the broader CMT phenotype. NCBI+1Cold or discolored feet
Because autonomic nerve involvement and poor muscle pumping can affect blood flow, some people notice that their feet feel cold, pale, or bluish, especially in cold weather or when sitting for long periods. This is usually mild but can add to discomfort. Wikipedia+1
Diagnostic tests
Physical examination tests
General neurological examination
The doctor checks muscle bulk, strength, reflexes, and sensation in arms and legs. In CMT2Q, this exam typically shows distal muscle wasting, weakness in the feet and ankles, reduced ankle reflexes, and mild sensory loss in a “stocking” pattern. NCBI+2Physiopedia+2Foot and ankle inspection
The clinician looks closely at the shape of the feet for pes cavus, hammertoes, and calluses, and at the calves for thinning. These visible signs give important clues that the weakness is chronic and likely hereditary rather than sudden. MalaCards+3NCBI+3ClinMed Journals+3Gait assessment and foot-drop testing
The doctor watches the person walk and may ask them to walk on heels or toes. Difficulty walking on heels or a high-stepping gait suggests foot drop and distal weakness, classic for axonal CMT including CMT2Q. Wikipedia+2NCBI+2Family history and pedigree review
Asking about relatives with similar foot problems, walking difficulty, or high arches helps identify an autosomal dominant family pattern. Drawing a family tree (pedigree) can strongly support the diagnosis of inherited CMT2Q. PMC+2Neurology Asia+2Screening for other systemic signs
The doctor also checks heart, lungs, and general health to make sure there are no signs of other systemic diseases (like diabetes complications or autoimmune disease) that could explain neuropathy instead of or in addition to CMT2Q. NCBI+2LearnHaem | Haematology Made Simple+2
Manual bedside tests
Manual muscle testing (MRC scale)
The examiner tests each muscle group by hand and grades strength from 0 to 5. In CMT2Q, there is usually weakness mainly in distal muscles (those farther from the trunk) such as ankle dorsiflexors, with relatively preserved proximal muscles. Physiopedia+1Vibration sense testing with tuning fork
A vibrating tuning fork is placed on bony points (ankle, toe joints). In CMT2Q, vibration sense is often reduced or absent in the feet, matching the mild to moderate deep sensory impairment described for this subtype. MalaCards+2NCBI+2Light touch and pinprick testing
The doctor gently touches the skin with cotton or a pin to see if sensation is normal, reduced, or different on both sides. CMT2Q usually causes distal loss of sensation to light touch and pain, but often milder than in some other neuropathies. Physiopedia+1Joint position (proprioception) testing
The examiner moves the patient’s toe or finger up or down and asks them, with eyes closed, to say which way it moved. In CMT2Q, people may struggle to detect small movements, showing loss of joint position sense. MalaCards+2NCBI+2Tendon reflex testing
Using a reflex hammer, the doctor taps the Achilles tendon and knee tendons. In CMT2Q, ankle reflexes are often reduced or absent, while knee reflexes may be relatively preserved, supporting a length-dependent peripheral neuropathy. MalaCards+2NCBI+2
Laboratory and pathological tests
Targeted DHTKD1 genetic testing
A blood sample can be sent for DNA analysis of DHTKD1. Finding a known pathogenic variant confirms the diagnosis of CMT2Q. Labs may use single-gene testing, CMT panels, or broader exome sequencing depending on local practice. Neurology Asia+4NCBI+4MalaCards+4CMT gene panel testing
Because many genes cause CMT, clinicians often order a multi-gene panel that includes DHTKD1 and other CMT genes. This approach is efficient when the precise subtype is unclear and helps rule out overlapping genetic neuropathies. MalaCards+2PMC+2Basic blood tests to rule out other neuropathies
Tests like fasting glucose or HbA1c (for diabetes), vitamin B12 and folate levels, thyroid function, kidney and liver tests, and sometimes autoimmune screens help exclude other treatable causes of neuropathy that could mimic or worsen CMT2Q. LearnHaem | Haematology Made Simple+2Physiopedia+2Metabolic testing for organic aciduria (if indicated)
In selected cases, especially if there are developmental or metabolic signs, urine and plasma organic acids can be measured to look for 2-aminoadipic and 2-oxoadipic aciduria, another disorder linked to DHTKD1 mutations. This does not define CMT2Q but helps understand the full metabolic picture. MalaCards+3PubMed+3Cell+3Nerve biopsy (rarely needed)
A small sample of a sensory nerve (often the sural nerve) can be removed and examined under a microscope. In axonal CMT like CMT2Q, biopsy shows loss of large myelinated fibers and axonal degeneration. Because biopsy is invasive, it is usually reserved for unclear or atypical cases. NCBI+2Muscular Dystrophy Association+2
Electrodiagnostic tests
Nerve conduction studies (NCS)
NCS measure how fast and how strongly electrical signals travel along nerves. In CMT2Q, the pattern is axonal: amplitudes of responses are reduced (fewer working axons), while conduction velocities are often near normal or only mildly slowed. This helps distinguish CMT2 from demyelinating forms. Wikipedia+3NCBI+3Orthobullets+3Electromyography (EMG)
EMG uses a small needle electrode to record electrical activity in muscles. In CMT2Q, EMG often shows chronic denervation in distal muscles (for example, in the foot and lower leg), with large, long-duration motor unit potentials that reflect long-standing axonal loss. Muscular Dystrophy Association+2NCBI+2Advanced electrodiagnostic protocols (if needed)
In some research or complex clinical settings, extra tests such as late responses (F-waves, H-reflex) or quantitative sensory testing may be used to better characterize the neuropathy, but they are not strictly required for standard diagnosis of CMT2Q. ScienceDirect+1
Imaging tests
X-ray of feet and ankles
Plain X-rays can show bone changes from pes cavus, hammertoes, and other deformities, such as increased arch height and toe contractures. While they do not show nerves, they help plan orthotic devices or surgery and document long-term skeletal effects of the neuropathy. ClinMed Journals+2ResearchGate+2Ultrasound or MRI of peripheral nerves and muscles
High-resolution ultrasound or MRI can visualize nerve size and muscle bulk. In CMT, these imaging methods may show atrophy of distal muscles and sometimes changes in peripheral nerves. They are mainly research or specialist tools but can support the diagnosis and exclude other structural problems. eMedicine+2ClinMed Journals+2
Non-pharmacological treatments (therapies and other approaches)
1. Structured physiotherapy and exercise program
Physiotherapy is the core non-drug treatment for CMT2Q. A therapist designs a regular exercise plan that includes stretching, strengthening, balance, and walking practice. The goal is to keep muscles working as long as possible, protect joints, and reduce the risk of contractures (permanent stiffness). For axonal CMT, studies show that supervised strength and endurance training can improve walking, balance, and daily activities without making the disease progress faster.PMC+2Lippincott Journals+2
2. Strength (resistance) training
Resistance training uses bands, weights, or body-weight exercises to gently load the muscles that are still able to respond. The purpose is to slow down muscle wasting, improve functional strength for stair climbing, standing up, and hand tasks, and reduce fatigue. The mechanism is the usual “use it or lose it”: repeated, safe loading of muscle fibers stimulates them to maintain size and function, even when nerves are partially damaged. Programs are kept low to moderate intensity and carefully monitored.PubMed+2CMT Australia+2
3. Stretching and contracture prevention
Because weak muscles cannot fully move the joints, tendons and ligaments can shorten and cause fixed deformities, especially in the ankles and toes. Daily stretching of calves, hamstrings, and toe flexors helps keep joints flexible and may delay pes cavus and toe clawing. Night splints or stretching braces can gently hold the foot in a better position during sleep. The mechanism is simple mechanical lengthening of soft tissues over time, which keeps the range of motion available for walking and brace fitting.PubMed+2Pod NMD+2
4. Balance and gait (walking) training
CMT2Q often causes unsteady walking due to foot drop, weak ankle muscles, and reduced sensation. Balance and gait training use tasks like walking on different surfaces, turning, stepping over obstacles, and static balance exercises. The goal is to reduce falls and make walking more efficient. These exercises train the brain and remaining nerves to use visual cues, core muscles, and hip strategies to compensate for weak ankles and impaired feeling in the feet.MDPI+2PubMed+2
5. Aerobic (endurance) exercise
Low-impact aerobic exercise such as walking in water, cycling, or swimming helps the heart and lungs and may reduce fatigue and improve mood. The purpose is not to “fix” the nerve damage but to maintain general fitness so that weak muscles can still do daily tasks with less effort. Studies in CMT show that aerobic training can improve work capacity and reduce overall tiredness without worsening neuropathy. Intensity is kept modest and adjusted individually.PubMed+2Pod NMD+2
6. Ankle-foot orthoses (AFOs) and bracing
Many people with CMT2Q develop foot drop and ankle instability. Lightweight plastic or carbon-fiber ankle-foot orthoses can hold the ankle in a safer position, reduce tripping, and improve walking speed. The mechanism is mainly mechanical support: the brace substitutes for weak ankle muscles, stores energy during stance, and helps lift the toes during swing. Correctly fitted AFOs can also reduce fatigue by making each step more efficient.Charcot-Marie-Tooth Association+2DelveInsight+2
7. Custom footwear and shoe inserts
High-arched, twisted feet can make standard shoes painful and unstable. Custom insoles, lateral or medial wedges, and extra-depth shoes help spread pressure, improve alignment, and reduce calluses and pain. The mechanism is redistribution of load and slight correction of foot posture during standing and walking. Good shoes and inserts also work together with AFOs and reduce the risk of skin breakdown, which is important in people with reduced sensation.PMC+2nhs.uk+2
8. Occupational therapy and hand training
Occupational therapists focus on hand weakness, fine motor skills, and how the person manages daily tasks like writing, using a phone, dressing, or working. Simple tools like thick-handled pens, adapted cutlery, button hooks, and keyboard modifications are used. Exercises strengthen the wrist and hand muscles that are still functional. The goal is to maintain independence and reduce frustration, using both muscle training and smart “work-around” strategies.CMT Australia+1
9. Assistive devices for mobility and safety
Canes, walking sticks, trekking poles, or rolling walkers may be needed when balance becomes poorer or longer distances are difficult. The purpose is to reduce falls, make walking less tiring, and allow outdoor mobility. Mechanically, these devices widen the base of support and allow the arms and trunk to share some of the load and control that weak legs cannot fully handle. Choosing the right height and device type is important and should be done with a therapist.PubMed+1
10. Home and workplace adaptations
Small environmental changes can make life much easier with CMT2Q. Examples include grab bars in the bathroom, non-slip mats, ramps instead of steps, and organizing tools within easy reach at work. The mechanism is risk reduction: by removing trip hazards and awkward movements, these changes lower the chance of falls and allow people to conserve energy. Occupational therapists often visit the home or school/workplace to suggest practical modifications.nhs.uk+1
11. Pain management techniques (non-drug)
Besides medicines, simple methods such as heat packs, warm baths, gentle massage, relaxation breathing, and mindfulness can help with chronic pain. These approaches aim to calm the nervous system, relax tense muscles, and shift attention away from pain. They do not change the nerve damage but can lower pain intensity and improve sleep and mood when used regularly together with other treatments.Mayo Clinic+2eMedicine+2
12. Fatigue management and energy conservation
Many people with CMT report tiredness because every step and task uses more effort. Energy-saving strategies include planning rest breaks, sitting for tasks when possible, using wheeled bags instead of carrying heavy loads, and dividing big tasks into smaller parts. The mechanism is simple: by reducing unnecessary energy burn, you preserve energy for important activities and may feel less exhausted at the end of the day.PubMed+2MDPI+2
13. Psychological support and counseling
Living with a rare, chronic disease can bring sadness, anxiety, or worry about the future. Psychological counseling, support groups, or online communities allow people to share experiences and learn coping skills. A calm, supported mind can improve pain control, adherence to exercise, and overall quality of life. This “mind-body” effect is now well recognized in chronic neurological diseases.MDPI+1
14. Genetic counseling for the family
Because CMT2Q is usually autosomal dominant, each child of an affected parent has a 50% chance of inheriting the mutation. Genetic counseling explains inheritance patterns, testing options, and reproductive choices in simple language. The mechanism is informational and emotional support: better understanding reduces fear and helps families make informed decisions about future pregnancies and early diagnosis.MalaCards+1
15. Vocational and school support
As weakness and fatigue grow, certain jobs or school tasks may become hard. Vocational rehabilitation specialists can suggest adjusted roles, flexible hours, or ergonomic tools to keep people employed or in education. In school-age patients, individualized education plans and extra time for exams can help. The aim is to protect participation in society and prevent disability from turning into social isolation.nhs.uk+1
16. Regular foot care and podiatry
Numb feet are at risk for unnoticed blisters, calluses, and ulcers. Regular visits to a podiatrist and daily self-inspection of the feet can catch small problems early. Nail care, callus removal, and advice about socks and shoes are important. The mechanism is prevention of infection and deformity: small skin problems can turn into serious wounds when sensation is reduced.nhs.uk+1
17. Weight management
Extra weight puts more strain on weak muscles and unstable joints and can speed up the loss of mobility. A balanced diet with appropriate calories and gentle exercise helps maintain a healthy body mass. This reduces stress on the feet and knees, makes braces more effective, and can improve energy levels. For people with CMT, maintaining a healthy weight is considered a key part of long-term management.European CMT Federation+2Charcot-Marie-Tooth Association+2
18. Smoking and alcohol reduction
Smoking harms blood vessels and nerves, and heavy alcohol use can cause its own neuropathy. For someone with CMT2Q, this double stress can make nerve damage worse or symptoms more severe. Stopping smoking and keeping alcohol intake low help protect remaining nerve function and general health.phoenixfai.com+1
19. Sleep hygiene and rest strategies
Poor sleep increases pain sensitivity and fatigue. Simple sleep hygiene—regular bedtimes, a quiet dark room, limiting screens before bed, and gentle stretches or relaxation—can improve sleep quality. Better sleep helps the brain process pain signals more calmly and supports mood and daytime energy.Mayo Clinic+1
20. Regular multidisciplinary follow-up
Because CMT2Q affects many aspects of life, regular visits to a team (neurologist, physiotherapist, orthotist, podiatrist, and sometimes surgeon, psychologist, and dietitian) are important. These visits allow early detection of worsening foot deformities, new pain, or falls. Adjustments in braces, therapy intensity, or work and school supports can then be made in time.nhs.uk+2PubMed+2
Drug treatments (symptom-focused, not curative)
Key point: No medicine is currently approved to cure or slow CMT2Q itself. Medicines are used to manage neuropathic pain, cramps, anxiety, sleep problems, and associated issues, using drugs that are FDA-approved for these symptoms in other conditions.eMedicine+1
Below are examples. Exact drug choice and dosing must always be decided by a specialist.
1. Pregabalin (Lyrica)
Pregabalin is often used for burning, shooting neuropathic pain. It binds to calcium channels on nerve cells and reduces the release of excitatory neurotransmitters, which calms overactive pain signals. The FDA label approves pregabalin for neuropathic pain in diabetic neuropathy, spinal cord injury, post-herpetic neuralgia, and fibromyalgia, not specifically for CMT, but doctors may use it off-label for similar pain. It is usually taken in divided doses each day, with slow dose increases. Common side effects include dizziness, sleepiness, weight gain, and swelling.FDA Access Data+2FDA Access Data+2
2. Duloxetine (Cymbalta and similar)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for neuropathic pain and depression. It works by increasing serotonin and noradrenaline in pain pathways in the brain and spinal cord, which helps reduce pain perception. The FDA has approved duloxetine for diabetic peripheral neuropathic pain and fibromyalgia. It is usually given once daily, and the dose is slowly increased according to response and side effects. Frequent side effects include nausea, dry mouth, constipation, and sleep changes.FDA Access Data+2FDA Access Data+2
3. Gabapentin
Gabapentin is another anticonvulsant widely used for nerve pain. Like pregabalin, it binds to certain calcium channel subunits and reduces the release of excitatory neurotransmitters. It is FDA-approved for seizures and post-herpetic neuralgia but often used off-label for other neuropathic pains. Doses are increased gradually, and common side effects include dizziness, tiredness, and swelling.eMedicine+1
4. Amitriptyline
Amitriptyline is a tricyclic antidepressant frequently used in low doses at night for neuropathic pain and to improve sleep. It blocks the reuptake of serotonin and noradrenaline and has additional actions on other receptors that can dampen pain signals. It is not specific for CMT but is part of general neuropathic pain management. Side effects can include dry mouth, constipation, weight gain, and morning grogginess, so it must be used carefully, especially in young people.eMedicine+1
5. Nortriptyline
Nortriptyline is similar to amitriptyline but is sometimes better tolerated. It works through the same neurotransmitter mechanisms and is used for neuropathic pain and sleep disturbance. It is usually started at a low dose and slowly increased. Side effects may include dry mouth, constipation, and mild dizziness, and heart rhythm should be monitored in older adults or those with heart disease.eMedicine+1
6. Tramadol (used with caution)
Tramadol is a weak opioid with SNRI-like action that may help severe neuropathic pain when other drugs fail. It acts on opioid receptors and also inhibits serotonin and noradrenaline reuptake. Because of risks of dependence, drowsiness, and interactions, many specialists use tramadol only short term and at the lowest effective dose. For young patients and those with CMT, non-opioid options are usually tried first.eMedicine+1
7. Non-steroidal anti-inflammatory drugs (NSAIDs)
Drugs like ibuprofen or naproxen may help mild musculoskeletal pain from overworked joints or tendons but are usually less effective for burning neuropathic pain. They work by blocking cyclo-oxygenase enzymes and lowering prostaglandin levels, which reduces inflammation. They are taken as needed, but overuse can harm the stomach, kidneys, and heart. They are often combined with other pain strategies rather than used alone for CMT-related pain.Mayo Clinic+1
8. Paracetamol (acetaminophen)
Paracetamol is commonly used for mild to moderate pain and fever. It likely acts in the brain on prostaglandin synthesis and pain pathways. It can be useful for background aches or after minor injuries in people with CMT2Q. It is generally safe at recommended doses, but overdosing can seriously damage the liver, so the total daily dose must not be exceeded.Mayo Clinic+1
9. Baclofen
Baclofen is a muscle relaxant acting on GABA-B receptors in the spinal cord. It is mainly used for spasticity, but some clinicians try it for painful muscle cramps in neuropathies. It reduces the over-activity of motor neurons that trigger muscle contractions. Side effects include drowsiness, weakness, and dizziness, so doses must be adjusted carefully.eMedicine+1
10. Tizanidine
Tizanidine is another antispasticity drug that acts on alpha-2 adrenergic receptors in the spinal cord, reducing muscle tone and spasms. In CMT2Q, it might be used off-label for severe cramps or muscle tightness. It can lower blood pressure and cause drowsiness, so monitoring is needed.eMedicine+1
11. Topical lidocaine patches or gels
Lidocaine patches (for example 5% patches) are FDA-approved for post-herpetic neuralgia and are sometimes used off-label for localized neuropathic pain elsewhere. They work by blocking sodium channels in local nerve endings, which stops them from firing pain signals. The patch is placed on painful skin areas for limited hours per day, with minimal systemic side effects.eMedicine+1
12. Topical capsaicin creams or patches
Capsaicin, the active compound in chili peppers, can desensitize certain pain fibers when applied repeatedly to the skin. High-dose patches are approved for certain neuropathic pains, and low-strength creams are available over the counter in many places. The mechanism is depletion of substance P and functional “defunctionalization” of pain fibers over time. Burning or redness at the application site is common at the beginning.eMedicine+1
13. SSRIs or SNRIs for mood and pain overlap
In some patients, anxiety and depression increase the impact of pain. SSRIs (like sertraline) and SNRIs (like venlafaxine) are antidepressants that can also help chronic pain in some people. They work by altering serotonin and noradrenaline signaling. Their main role in CMT2Q is to treat mood symptoms, which indirectly improves pain coping and quality of life.Mayo Clinic+1
14. Sleep aids (used very cautiously)
Short-term use of certain sleep medicines may be considered in severe insomnia. However, many sedatives increase fall risk and daytime drowsiness, which is dangerous when leg muscles are weak. Because of this risk, most guidelines favor non-drug sleep hygiene and psychological methods before using pills. Any sleep medicine must be chosen and monitored by a physician.Mayo Clinic+1
15–20. Other symptomatic drugs
Depending on individual problems, doctors may use medications for orthostatic dizziness, bladder issues, or constipation. There is no specific “CMT2Q drug list”; instead, treatment borrows from general neurology and pain guidelines. The common principle is to start at low doses, increase slowly, and regularly review benefit and side effects.eMedicine+1
Dietary molecular supplements (experimental and supportive)
Very important: None of these supplements are proven to treat CMT2Q. Evidence is often from other neuropathies or small studies. Always discuss with a doctor, especially as a teenager.
Alpha-lipoic acid – An antioxidant used in diabetic neuropathy studies. It may reduce oxidative stress in nerves and support energy metabolism in mitochondria. Some people report reduced burning pain, but data in CMT are limited.Optimum Health Clinic+1
Acetyl-L-carnitine – Carnitine helps transport fatty acids into mitochondria. Supplementation may support mitochondrial function and nerve regeneration in some neuropathy models, but human evidence is mixed.Optimum Health Clinic+1
Coenzyme Q10 (ubiquinone) – A key component of the mitochondrial electron transport chain. It may help cells produce energy and fight oxidative stress. It is sometimes used in mitochondrial diseases and neuropathies, but robust data in CMT2Q are lacking.Wikipedia+1
Omega-3 fatty acids (fish oil) – Omega-3s have anti-inflammatory effects and support cell membrane health. They may help general cardiovascular health and possibly nerve health, but direct evidence in CMT is limited.European CMT Federation+1
Vitamin D – Vitamin D supports bone health and immune function. Low vitamin D is common in chronic illness and may worsen muscle weakness. Correcting deficiency is standard, though it does not directly treat CMT.European CMT Federation+1
B-complex vitamins (especially B1, B6, B12) – These vitamins are important for nerve function. Severe deficiency can cause neuropathy. In CMT2Q, supplements mainly prevent additional damage from deficiency but do not repair the inherited neuropathy.Apollo Hospitals+1
Magnesium – Often used for muscle cramps. Magnesium helps muscles relax after contraction. Evidence is mixed, but some people report fewer cramps when deficiency is corrected.eMedicine+1
Curcumin (turmeric extract) – Has anti-inflammatory and antioxidant properties. Animal studies in other nerve conditions suggest possible protection, but data in human CMT are lacking, so it should be seen as a general anti-inflammatory, not a disease treatment.Charcot-Marie-Tooth News+1
Green tea extract (EGCG) – One small case report described metabolic and functional improvements in a CMT2 patient treated with epigallocatechin gallate, a green tea polyphenol with antioxidant and anti-inflammatory actions. This is promising but very early evidence.PMC
General antioxidant mixes – Some people take mixed antioxidant supplements (vitamins C and E, selenium, etc.). While they may support general health, there is no strong proof that they change the course of CMT2Q.Optimum Health Clinic+1
Regenerative, immunity booster, and stem-cell-related drugs
At present, no stem cell or regenerative drug is approved for CMT2Q. Several experimental strategies are being studied mainly in more common types like CMT1A.
Experimental skeletal muscle–targeted drugs (e.g., NMD670) – NMD670 is an oral experimental drug aimed at increasing muscle responsiveness to weak nerve signals, so muscles contract better even when nerves are damaged. It is in clinical trials and not yet approved. Dosing is controlled inside studies only.NMD Pharma
Gene-silencing therapies (ASO, siRNA, shRNA) – For CMT1A, researchers are testing molecules that reduce over-expressed PMP22 gene. The concept is to correct the toxic protein balance at the DNA or RNA level. Similar approaches could, in theory, be adapted to DHTKD1-related CMT2Q, but this is not yet in clinical trials.PubMed+1
CRISPR-based gene editing – Experimental work is exploring CRISPR-Cas9 systems to correct genetic defects in CMT at the DNA level. At the moment, this remains in early research and animal models, with many safety hurdles before human use.PubMed+1
Mesenchymal stem cell (MSC) therapies – Some small studies in other neuropathies and animal models suggest that MSCs may release growth factors that support nerve repair. For CMT, evidence is still very low, and such treatments should only be considered in well-designed clinical trials.PubMed+1
Neurotrophic factor delivery – Research is ongoing into ways of delivering nerve growth factors (like NGF or GDNF) to damaged nerves using viral vectors or encapsulated cells. The mechanism is to provide strong survival and growth signals to axons and supporting Schwann cells. This is not yet ready for routine care.PubMed+1
Immunomodulatory therapies (only for misdiagnosis/overlap) – Standard immune therapies such as IVIG or steroids are not treatments for pure genetic CMT2Q, but they may be used when doctors suspect an overlapping immune neuropathy. Their role in true DHTKD1-related CMT2Q is minimal.eMedicine+1
Surgical treatments (procedures and why they are done)
Tendon transfer surgery – In CMT, some muscles are overly tight while others are weak. Surgeons can detach a functioning tendon (like the posterior tibial tendon) and reattach it in a new position to balance foot movement. The goal is to correct foot drop and cavovarus deformity, so the foot becomes more plantigrade (flat on the ground) and stable for walking and brace use.PMC+2Charcot-Marie-Tooth Association+2
Osteotomy (bone realignment) – When bones in the foot have become rigidly deformed, surgeons may cut and realign them (for example, calcaneal or first metatarsal osteotomy). The purpose is to correct structural deformities such as high arches and twisted heels, improving weight distribution and reducing pain.PMC+2eMedicine+2
Soft tissue release – Tight plantar fascia, ligaments, or tendons can be surgically lengthened or released. This is often combined with tendon transfers or osteotomies. The mechanism is to free up stiff structures so the foot can be repositioned into a more functional alignment.PMC+2Charcot-Marie-Tooth Association+2
Toe correction procedures – Clawed toes can be straightened with tendon lengthening or fusion of small joints. This reduces pressure points, pain, and the risk of ulcers at the tips of the toes. It also makes shoe fitting easier and improves the cosmetic appearance of the foot.Charcot-Marie-Tooth Disease+2PMC+2
Joint fusion (arthrodesis) as a last resort – In severe, rigid deformities that cannot be corrected by softer procedures, fusion of certain joints may be performed to create a stable, pain-free foot. Modern practice tries to limit fusions, because they reduce movement, but they can be very helpful in carefully chosen cases.Charcot-Marie-Tooth Disease+2PMC+2
Prevention and lifestyle tips
Keep a healthy weight to reduce stress on weak muscles and deformed feet.European CMT Federation+1
Do regular low-impact exercise (swimming, cycling, walking) to protect fitness without over-loading joints.Charcot-Marie-Tooth Association+1
Use braces and orthotics early when foot drop or instability appears, to prevent repeated sprains and falls.Pod NMD+1
Inspect and care for your feet daily to catch blisters or wounds early.nhs.uk+1
Avoid neurotoxic medicines (for example, certain chemotherapy drugs) whenever safer alternatives exist; your doctor will guide this.eMedicine+1
Do not smoke and limit alcohol, as both can worsen nerve damage and circulation.phoenixfai.com+1
Maintain good sleep and mental health, since poor sleep and stress increase pain and fatigue.Mayo Clinic+1
Keep vaccinations up to date and manage infections promptly, because infections and fever can temporarily worsen weakness.Mayo Clinic+1
Follow regular check-ups with your neurologist and rehabilitation team to adjust braces, therapies, and medicines in time.nhs.uk+1
Educate family and teachers/employers so they understand your limitations and can help create a safe environment.phoenixfai.com+1
When to see doctors
You should see a doctor (preferably a neurologist familiar with CMT) or go back for review if:
You notice new or rapidly worsening weakness, especially if it seems much faster than your past pattern.eMedicine+1
You develop severe new pain, burning, or electric shocks in the feet or hands that do not settle with usual measures.Mayo Clinic+1
You start to fall more often or feel very unsteady, suggesting that braces or therapy need updating.PubMed+1
You see wounds, ulcers, or infections on your feet, especially if you have poor sensation.nhs.uk+1
You notice changes in bladder or bowel control, which are not typical of CMT and need checking.eMedicine+1
You have mood problems (low mood, anxiety, thoughts of giving up), which can and should be treated.Mayo Clinic+1
For a teenager, it is best to attend visits with a parent or guardian so everyone understands the plan.
What to eat and what to avoid
Eat plenty of fruits and vegetables, especially green leafy vegetables and colorful plants, which provide antioxidants and anti-inflammatory nutrients.European CMT Federation+1
Choose lean proteins such as fish, poultry, beans, and lentils to support muscle repair without excess saturated fat.European CMT Federation+1
Include healthy fats from sources like olive oil, nuts, seeds, and oily fish, which may support nerve membranes and reduce inflammation.European CMT Federation+1
Prefer whole grains (brown rice, oats, whole-wheat bread) over refined carbohydrates to keep energy steady and avoid large sugar spikes.European CMT Federation+1
Limit sugary drinks, sweets, and highly processed snacks, which promote inflammation and weight gain and may make CMT symptoms feel worse.Charcot-Marie-Tooth News+1
Avoid very salty, high-fat fast food most of the time, to protect heart health and weight.European CMT Federation+1
Stay well hydrated with water; mild dehydration can worsen fatigue and cramps.European CMT Federation+1
If you are overweight, work with a dietitian to create a mild calorie deficit while keeping good nutrition; weight loss can ease stress on your feet.European CMT Federation+1
If you try special diets (like high-fat or ketogenic diets), do so only under specialist supervision, since evidence in CMT comes mainly from animal studies and safety in humans is not fully known.Optimum Health Clinic+1
Avoid excess caffeine and alcohol, which can disturb sleep and, in high amounts, harm nerves.phoenixfai.com+1
Frequently asked questions (FAQs)
1. Is CMT2Q life-threatening?
CMT2Q usually progresses slowly and mainly affects movement and sensation in the limbs. For most people it does not shorten life, but it can cause disability and affect quality of life. Serious complications are more likely if falls, fractures, or severe foot ulcers occur and are not managed early.MalaCards+1
2. Can CMT2Q be cured?
At present, no cure exists and no approved drug has been proven to stop or reverse CMT2Q. Research in gene therapy and regenerative medicine is ongoing, but for now treatment focuses on symptom control and maintaining function with rehabilitation, braces, and surgery when needed.PMC+2eMedicine+2
3. Will exercise make my nerves worse?
Current evidence suggests that moderate, supervised exercise does not damage nerves in CMT and can improve strength, endurance, and daily function. Very intense or unplanned exercise that causes repeated injuries should be avoided. Following a program designed by a physiotherapist is the safest approach.Lippincott Journals+2PubMed+2
4. Why are braces recommended?
Braces such as AFOs compensate for weak muscles and unstable ankles. They help prevent falls, improve walking speed, and can reduce fatigue. Using them early does not weaken the muscles; instead, it allows safer activity and often improves independence.Charcot-Marie-Tooth Association+2Pod NMD+2
5. Do all people with CMT2Q need surgery?
No. Many people manage well with physiotherapy, orthotics, and lifestyle changes. Surgery is considered when deformities are rigid, painful, or causing repeated sprains or ulcers, and when conservative measures are not enough.PMC+2eMedicine+2
6. Can diet alone treat CMT2Q?
Diet cannot fix the underlying gene problem, but a healthy diet supports overall health, weight control, and possibly inflammation levels. Good nutrition makes it easier to stay active and may reduce some secondary problems, but it is not a stand-alone treatment for CMT2Q.European CMT Federation+2Charcot-Marie-Tooth Disease+2
7. Should I take supplements?
Supplements like vitamins or omega-3s may help if you have a deficiency or poor diet, but strong evidence for specific supplements in CMT2Q is limited. You should never start many supplements at once or high doses without medical advice, because some can interact with medicines.Optimum Health Clinic+2PMC+2
8. Can children be tested for CMT2Q?
Genetic testing can confirm DHTKD1 mutations. For children, testing decisions are usually made after discussion with genetic counselors and parents, considering benefits (early support, avoiding certain drugs) and emotional impact.MalaCards+2SciELO+2
9. Is pregnancy safe for someone with CMT2Q?
Many people with CMT have normal pregnancies, but extra care is needed because of balance problems, weight gain, and possible increased fatigue. There is also a 50% chance of passing on the mutation in autosomal dominant cases. Obstetric and genetic counseling before pregnancy is recommended.eMedicine+1
10. Are there medicines I should avoid?
Some medicines, especially certain chemotherapy drugs like vincristine, are known to be toxic to peripheral nerves and are usually avoided or used with extreme caution in people with CMT. Always remind any doctor or dentist that you have CMT so they can check drug choices.eMedicine+1
11. Can I play sports?
Many people with CMT2Q can do low-impact sports such as swimming, cycling, or carefully supervised gym training. High-impact sports with a high risk of ankle sprain or falls (for example, contact sports) may be less safe, especially without braces. The exact choice depends on your strength, balance, and medical advice.Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2
12. Does CMT2Q affect thinking or memory?
CMT2Q is primarily a peripheral nerve disorder. In typical cases, it does not affect intelligence or memory. Rare reports describe unusual combinations with other problems, but these are exceptions. Most people have normal thinking abilities.MalaCards+2SciELO+2
13. Is CMT2Q common?
No. CMT2Q is very rare, with a point prevalence estimated at less than 1 in 1,000,000 in the general population. Only a small number of families with proven DHTKD1 mutations have been described worldwide so far.MalaCards+2SciELO+2
14. How often should I see my neurologist?
The ideal schedule depends on how fast your symptoms change. Many experts suggest at least yearly follow-up, and more often during times of rapid change (adolescence, pregnancy, or after surgery). This allows timely adjustment of therapies and braces.nhs.uk+1
15. What is the long-term outlook?
CMT2Q usually progresses slowly over many years. Many people remain able to walk, often with braces or after foot surgery. Early and continuous rehabilitation, good foot care, and smart lifestyle choices can make a big difference in preserving function and independence, even though the underlying gene change remains.MalaCards+2PMC+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
